A randomized, double blind, placebo-controlled, 2-period cross over study to evaluate effects of S-555739 on prostaglandin D2 (PGD2) induced nasal airway resistance in healthy adult volunteers.
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Asapiprant (Primary)
- Indications Allergic rhinitis
- Focus Pharmacodynamics
- 01 Aug 2011 New trial record